Literature DB >> 2364997

The effects of taurine on atherosclerosis development in cholesterol-fed rabbits.

M A Petty1, J Kintz, G F DiFrancesco.   

Abstract

The effect of taurine on the development of atherosclerotic lesions in rabbits maintained on a 2% cholesterol diet for a 14 week period has been examined. Taurine (0.2 and 0.5%) administered in the drinking water reduced thoracic aorta involvement. The area covered by atherosclerotic lesions was 58 +/- 15 and 52.5 +/- 12% (P less than 0.05) respectively, compared to 72.4 +/- 19% in the control group. Taurine had no significant effect on serum or tissue cholesterol, calcium, triglyceride or phospholipid concentrations. Nevertheless 0.2% taurine caused an increase in dP/dtmax (measured from the systemic blood pressure) and 0.5% lowered systemic blood pressure. The anti-atherosclerotic effects of taurine appear to be unrelated to a fall in blood pressure. The possibility that taurine is reducing the development of atherosclerotic lesions through a mechanism involving its antioxidant activity is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364997     DOI: 10.1016/0014-2999(90)90599-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Angela M Nivala; Jon C Gonzales; Kyle T Pfaffenbach; Dong Wang; Yuren Wei; Hua Jiang; David J Orlicky; Dennis R Petersen; Michael J Pagliassotti; Kenneth N Maclean
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

Review 2.  Practical strategies for modulating foam cell formation and behavior.

Authors:  Elisabeth Uitz; Babak Bahadori; Mark F McCarty; Mohammed H Moghadasian
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 3.  Myeloperoxidase: a target for new drug development?

Authors:  E Malle; P G Furtmüller; W Sattler; C Obinger
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

Review 4.  Is taurine beneficial in reducing risk factors for diabetes mellitus?

Authors:  Flavia Franconi; Mauro A S Di Leo; Federico Bennardini; Giovanni Ghirlanda
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

5.  Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease.

Authors:  Chen N Young; Jay I Koepke; Laura J Terlecky; Michael S Borkin; Savoy L Boyd; Stanley R Terlecky
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

6.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

Review 7.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

8.  Chemopreventive effects of taurine on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats.

Authors:  K Okamoto; S Sugie; M Ohnishi; H Makita; T Kawamori; T Watanabe; T Tanaka; H Mori
Journal:  Jpn J Cancer Res       Date:  1996-01

Review 9.  Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes.

Authors:  Bozidarka L Zaric; Jelena N Radovanovic; Zoran Gluvic; Alan J Stewart; Magbubah Essack; Olaa Motwalli; Takashi Gojobori; Esma R Isenovic
Journal:  Front Immunol       Date:  2020-09-28       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.